By expenditures
| Name | Title | Type |
|---|---|---|
| Leslie Wilson | Partner | Auditee |
| Oran Woodworth | Sr. Vp Business Affairs | Auditee |
| Elizabeth Knysak | MANAGING DIRECTOR | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 387298 | 2025 | 2026-02-13 | FORVIS MAZARS LLP | $20.97M |
| 326979 | 2024 | 2024-11-01 | Forvis Mazars LLP | $20.29M |
| 1585 | 2023 | 2023-10-27 | Forvis | $20.12M |
| 30657 | 2022 | 2022-10-30 | Forvis | $24.34M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 387298 | 2025 | 2026-02-13 | 1173578 | 2025-002 | Material Weakness | Yes | N |
| 387298 | 2025 | 2026-02-13 | 1173577 | 2025-002 | Material Weakness | Yes | N |
| 326979 | 2024 | 2024-11-01 | 1080864 | 2024-002 | Significant Deficiency | Yes | N |
| 326979 | 2024 | 2024-11-01 | 1080863 | 2024-002 | Significant Deficiency | Yes | N |
| 326979 | 2024 | 2024-11-01 | 1080862 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 1080861 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 1080860 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 1080859 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 504422 | 2024-002 | Significant Deficiency | Yes | N |
| 326979 | 2024 | 2024-11-01 | 504421 | 2024-002 | Significant Deficiency | Yes | N |
| 326979 | 2024 | 2024-11-01 | 504420 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 504419 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 504418 | 2024-001 | Material Weakness | - | N |
| 326979 | 2024 | 2024-11-01 | 504417 | 2024-001 | Material Weakness | - | N |
| 1585 | 2023 | 2023-10-27 | 577285 | 2023-001 | Significant Deficiency | - | N |
| 1585 | 2023 | 2023-10-27 | 577284 | 2023-001 | Significant Deficiency | - | N |
| 1585 | 2023 | 2023-10-27 | 843 | 2023-001 | Significant Deficiency | - | N |
| 1585 | 2023 | 2023-10-27 | 842 | 2023-001 | Significant Deficiency | - | N |